Followers | 9844 |
Posts | 260028 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Tuesday, November 05, 2019 5:15:30 PM
Link to Video - click here to watch the technical chart video
Recent NXTC News
- NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024 • GlobeNewswire Inc. • 09/16/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:12 PM
- NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 08:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:10:58 PM
- NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024 • GlobeNewswire Inc. • 05/30/2024 08:05:00 PM
- NextCure Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024 • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board • GlobeNewswire Inc. • 04/04/2024 11:05:00 AM
- NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- NextCure Provides Business Update and Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 12:55:00 PM
- NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances • GlobeNewswire Inc. • 03/05/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:45:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:44:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:44:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:43:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:43:21 PM
- NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury • GlobeNewswire Inc. • 12/21/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 12:15:59 PM
- NextCure Provides Year-End Clinical Pipeline Updates • GlobeNewswire Inc. • 12/14/2023 11:45:00 AM
- NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/20/2023 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM